Recurrent Rectal Cancer Active Not Recruiting Phase 1 Trials for Fluorouracil (DB00544)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270606Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerTreatment
NCT01740648Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal CancerTreatment